https://ctv.veeva.com/study/combined-dose-finding-and-cv-outcomes-study-with-csl300-clazakizumab-in-adult-subjects-with-eskd-u
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD...
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding...